<?xml version="1.0" encoding="UTF-8"?>
<table-wrap id="T3" orientation="portrait" position="float">
 <label>Table 3.</label>
 <caption>
  <p>Crude Incidence Rate and Results of Survival Analyses of Associations Between Prior Infection and Protection Against Subsequent Febrile Respiratory Illness (FRI) Among Major Basic Military Training (BMT) Intake Types</p>
 </caption>
 <table frame="vsides" rules="groups">
  <thead>
   <tr>
    <th rowspan="1" colspan="1"/>
    <th colspan="2" rowspan="1">Model 1
     <sup>b,c</sup>
    </th>
    <th colspan="2" rowspan="1">Model 2
     <sup>b,d</sup>
    </th>
    <th colspan="2" rowspan="1">Model 3
     <sup>b,e</sup>
    </th>
   </tr>
   <tr>
    <th rowspan="1" colspan="1">Variable
     <sup>a</sup>
    </th>
    <th rowspan="1" colspan="1">HR (95% CI)</th>
    <th rowspan="1" colspan="1">
     <italic>P</italic>
    </th>
    <th rowspan="1" colspan="1">HR (95% CI)</th>
    <th rowspan="1" colspan="1">
     <italic>P</italic>
    </th>
    <th rowspan="1" colspan="1">HR (95% CI)</th>
    <th rowspan="1" colspan="1">
     <italic>P</italic>
    </th>
   </tr>
  </thead>
  <tbody>
   <tr>
    <td rowspan="1" colspan="1">Virus in prior episode (vs no virus identified)</td>
    <td rowspan="1" colspan="1"/>
    <td rowspan="1" colspan="1"/>
    <td rowspan="1" colspan="1"/>
    <td rowspan="1" colspan="1"/>
    <td rowspan="1" colspan="1"/>
    <td rowspan="1" colspan="1"/>
   </tr>
   <tr>
    <td rowspan="1" colspan="1"> AdV</td>
    <td rowspan="1" colspan="1">.24 (.14–.44)</td>
    <td rowspan="1" colspan="1">&lt;.001</td>
    <td rowspan="1" colspan="1">.27 (.15–.47)</td>
    <td rowspan="1" colspan="1">&lt;.001</td>
    <td rowspan="1" colspan="1">.24 (.12–.47)</td>
    <td rowspan="1" colspan="1">&lt;.001</td>
   </tr>
   <tr>
    <td rowspan="1" colspan="1"> CoV</td>
    <td rowspan="1" colspan="1">1.07 (.77–1.49)</td>
    <td rowspan="1" colspan="1">.685</td>
    <td rowspan="1" colspan="1">1.12 (.81–1.54)</td>
    <td rowspan="1" colspan="1">.501</td>
    <td rowspan="1" colspan="1">1.35 (.91–2.02)</td>
    <td rowspan="1" colspan="1">.136</td>
   </tr>
   <tr>
    <td rowspan="1" colspan="1"> ERV</td>
    <td rowspan="1" colspan="1">.91 (.71–1.15)</td>
    <td rowspan="1" colspan="1">.423</td>
    <td rowspan="1" colspan="1">.90 (.71–1.14)</td>
    <td rowspan="1" colspan="1">.397</td>
    <td rowspan="1" colspan="1">.89 (.66–1.18)</td>
    <td rowspan="1" colspan="1">.410</td>
   </tr>
   <tr>
    <td rowspan="1" colspan="1"> hMPV</td>
    <td rowspan="1" colspan="1">.91 (.52–1.59)</td>
    <td rowspan="1" colspan="1">.734</td>
    <td rowspan="1" colspan="1">.97 (.57–1.67)</td>
    <td rowspan="1" colspan="1">.915</td>
    <td rowspan="1" colspan="1">1.01 (.51–2.00)</td>
    <td rowspan="1" colspan="1">.983</td>
   </tr>
   <tr>
    <td rowspan="1" colspan="1"> FluV</td>
    <td rowspan="1" colspan="1">.52 (.38–.73)</td>
    <td rowspan="1" colspan="1">&lt;.001</td>
    <td rowspan="1" colspan="1">.54 (.38–.74)</td>
    <td rowspan="1" colspan="1">&lt;.001</td>
    <td rowspan="1" colspan="1">.50 (.34–.74)</td>
    <td rowspan="1" colspan="1">.001</td>
   </tr>
   <tr>
    <td rowspan="1" colspan="1"> hPIV</td>
    <td rowspan="1" colspan="1">.98 (.58–1.64)</td>
    <td rowspan="1" colspan="1">.930</td>
    <td rowspan="1" colspan="1">1.02 (.62–1.69)</td>
    <td rowspan="1" colspan="1">.938</td>
    <td rowspan="1" colspan="1">1.09 (.59–2.00)</td>
    <td rowspan="1" colspan="1">.780</td>
   </tr>
   <tr>
    <td rowspan="1" colspan="1"> RSV</td>
    <td rowspan="1" colspan="1">1.80 (.52–6.22)</td>
    <td rowspan="1" colspan="1">.351</td>
    <td rowspan="1" colspan="1">1.94 (.58–6.43)</td>
    <td rowspan="1" colspan="1">.281</td>
    <td rowspan="1" colspan="1">2.96 (.71–12.31)</td>
    <td rowspan="1" colspan="1">.136</td>
   </tr>
   <tr>
    <td rowspan="1" colspan="1">FRI incidence rate by time from enlistment (per 1000 person-days)</td>
    <td rowspan="1" colspan="1">Omitted</td>
    <td rowspan="1" colspan="1"/>
    <td rowspan="1" colspan="1">1.44 (1.16–1.78)</td>
    <td rowspan="1" colspan="1">.001</td>
    <td rowspan="1" colspan="1">1.87 (1.41–2.49)</td>
    <td rowspan="1" colspan="1">&lt;.001</td>
   </tr>
   <tr>
    <td rowspan="1" colspan="1"> Subinterval ending &lt;4 wk after prior episode (vs ≥4 wks)</td>
    <td rowspan="1" colspan="1">…</td>
    <td rowspan="1" colspan="1"/>
    <td rowspan="1" colspan="1">Omitted</td>
    <td rowspan="1" colspan="1"/>
    <td rowspan="1" colspan="1">.43 (.30–.61)</td>
    <td rowspan="1" colspan="1">&lt;.001</td>
   </tr>
   <tr>
    <td rowspan="1" colspan="1">Type of BMT intake (vs 19 wk)</td>
    <td rowspan="1" colspan="1"/>
    <td rowspan="1" colspan="1"/>
    <td rowspan="1" colspan="1"/>
    <td rowspan="1" colspan="1"/>
    <td rowspan="1" colspan="1"/>
    <td rowspan="1" colspan="1"/>
   </tr>
   <tr>
    <td rowspan="1" colspan="1"> 17 wk</td>
    <td rowspan="1" colspan="1">.83 (.63–1.09)</td>
    <td rowspan="1" colspan="1">.181</td>
    <td rowspan="1" colspan="1">.83 (.64–1.09)</td>
    <td rowspan="1" colspan="1">.175</td>
    <td rowspan="1" colspan="1">.81 (.59–1.12)</td>
    <td rowspan="1" colspan="1">.205</td>
   </tr>
   <tr>
    <td rowspan="1" colspan="1"> 9 wk</td>
    <td rowspan="1" colspan="1">.43 (.27–.70)</td>
    <td rowspan="1" colspan="1">.001</td>
    <td rowspan="1" colspan="1">.42 (.26–.68)</td>
    <td rowspan="1" colspan="1">&lt;.001</td>
    <td rowspan="1" colspan="1">.46 (.26–.81)</td>
    <td rowspan="1" colspan="1">.007</td>
   </tr>
   <tr>
    <td rowspan="1" colspan="1"> Other
     <sup>f</sup>
    </td>
    <td rowspan="1" colspan="1">1.31 (.57–3.01)</td>
    <td rowspan="1" colspan="1">.524</td>
    <td rowspan="1" colspan="1">Omitted</td>
    <td rowspan="1" colspan="1"/>
    <td rowspan="1" colspan="1">Omitted</td>
    <td rowspan="1" colspan="1"/>
   </tr>
  </tbody>
 </table>
 <table-wrap-foot>
  <fn id="fn-0106">
   <p>Abbreviations: AdV, adenovirus; CI, confidence interval; CoV, coronavirus; ERV, enterovirus/rhinovirus; FluV, influenza virus; HR, hazard ratio; hMPV, human metapneumovirus; hPIV, human parainfluenza virus; RSV, respiratory syncytial virus.</p>
  </fn>
  <fn id="fn-0107">
   <p>
    <sup>a</sup>Only variables with results significant at 
    <italic>P</italic> &lt; .05 are shown in the table.
   </p>
  </fn>
  <fn id="fn-0108">
   <p>
    <sup>b</sup>All models were adjusted for study year, type of BMT intake, age, ethnicity, smoking history, history of asthma, and influenza vaccination.
   </p>
  </fn>
  <fn id="fn-0109">
   <p>
    <sup>c</sup>Not adjusted for FRI incidence rate by time from enlistment or for timing of interval relative to the prior consultation episode. All episodes are included as exposures and events of interest. All BMT types are included.
   </p>
  </fn>
  <fn id="fn-0110">
   <p>
    <sup>d</sup>Adjusted for FRI incidence rate by time from enlistment, expressed as FRI episodes per 1000 enlistee days (as defined and illustrated in methods and 
    <xref ref-type="fig" rid="F1">Figure 1B</xref>), but not for timing of interval relative to the prior consultation episode. All episodes are included as exposures and events of interest. Only the 19-week, 17-week, and 9-week BMT types are included.
   </p>
  </fn>
  <fn id="fn-0111">
   <p>
    <sup>e</sup>Adjusted for the FRI incidence rate by the time since enlistment, expressed as the number of FRI episodes per 1000 enlistee-days (as defined and illustrated in Methods and 
    <xref ref-type="fig" rid="F1">Figure 1B</xref>), and for whether the interval assessed was &lt;4 weeks or ≥4 weeks after the prior episode. The initial episode is the exposure of interest, and the second episode is the event of interest. Only the 19-week, 17-week, and 9-week BMT types are included.
   </p>
  </fn>
  <fn id="fn-0112">
   <p>
    <sup>f</sup>A mix of shorter BMT intake types.
   </p>
  </fn>
 </table-wrap-foot>
</table-wrap>
